Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus
- PMID: 31376424
- DOI: 10.1016/j.neuropharm.2019.107731
Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus
Abstract
Disruption of the hypothalamic-pituitary-adrenal axis is an established finding in patients with anxiety and/or depression. Chronic corticosterone administration in animals has been proposed as a model for the study of these stress-related disorders and the antidepressant action. Alterations of the central noradrenergic system and specifically of inhibitory α2-adrenoceptors seem to be part of the pathophysiology of depression and contribute to the antidepressant activity. The present study evaluates in male rats the effect of chronic corticosterone treatment during 35 days (16-20 mg kg-1 day-1) on the sensitivity of α2-adrenoceptors expressed in the somatodendritic and terminal noradrenergic areas locus coeruleus (LC) and prefrontal cortex (PFC), respectively. Further, the effect of chronic fluoxetine treatment (5 mg kg-1, i.p., since the 15th day) on the sensitivity of α2-adrenoceptors was examined under control conditions and in corticosterone-treated rats. The α2-adrenoceptor functionality was analysed in vitro by agonist-mediated [35S]GTPγS binding stimulation and in vivo through the modulation of noradrenaline (NA) release evaluated by dual-probe microdialysis. The concentration-effect curves of the [35S]GTPγS binding stimulation by the agonist UK14304 (5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine) demonstrated a desensitization of cortical α2-adrenoceptors induced by corticosterone (-logEC50 = 6.7 ± 0.2 vs 8.2 ± 0.3 in controls) that was reverted by fluoxetine treatment (-logEC50 = 7.5 ± 0.3). Local administration of the α2-adrenoceptor antagonist RS79948 ((8aR,12aS,13aS)-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-methoxy-12-(ethylsulfonyl)-6H-isoquino[2,1-g][1,6]naphthyridine) (0.1-100 μmol L-1) into the LC induced a concentration-dependent NA increase in the PFC of the control group (Emax = 191 ± 30%) but non-significant effect was observed in corticosterone-treated rats (Emax = 133 ± 46%), reflecting a desensitization of α2-adrenoceptors that control the firing of noradrenergic neurons. Fluoxetine treatment did not alter the corticosterone-induced desensitization in this area (Emax = 136 ± 19%). No effect of fluoxetine on α2-adrenoceptor functionality was observed in control animals (Emax = 223 ± 30%). In PFC, the local administration of RS79948 increased NA in controls (Emax = 226 ± 27%) without effect in the corticosterone group (Emax = 115 ± 26%), suggesting a corticosterone-induced desensitization of terminal α2-adrenoceptors. Fluoxetine administration prevented the desensitization induced by corticosterone in the PFC (Emax = 233 ± 33%) whereas desensitized α2-adrenoceptors in control animals (Emax = -24 ± 10%). These data indicate that chronic corticosterone increases noradrenergic activity by acting at different α2-adrenoceptor subpopulations. Treatment with the antidepressant fluoxetine seems to counteract these changes by acting mainly on presynaptic α2-adrenoceptors expressed in terminal areas.
Keywords: Adrenoceptor; Antidepressant; Corticosterone; Desensitization; Fluoxetine; Mood disorders.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain.Neuropharmacology. 2017 Mar 1;114:114-122. doi: 10.1016/j.neuropharm.2016.11.025. Epub 2016 Nov 28. Neuropharmacology. 2017. PMID: 27908769
-
Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study.Psychopharmacology (Berl). 2016 Dec;233(23-24):3861-3867. doi: 10.1007/s00213-016-4418-3. Epub 2016 Sep 4. Psychopharmacology (Berl). 2016. PMID: 27592231
-
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:97-103. doi: 10.1016/j.pnpbp.2018.11.015. Epub 2018 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30472147
-
Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):819-27. doi: 10.1016/j.pnpbp.2004.05.026. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15363606 Review.
-
DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.Neurotox Res. 2015 Jan;27(1):15-30. doi: 10.1007/s12640-014-9482-z. Epub 2014 Jun 26. Neurotox Res. 2015. PMID: 24964753 Review.
Cited by
-
Noradrenergic Regulation of the Medial Prefrontal Cortex Mediates Stress Coping in Postpartum Female Mice.Mol Neurobiol. 2024 Jun 3. doi: 10.1007/s12035-024-04240-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 38829510
-
Therapeutic treatment with fluoxetine using the chronic unpredictable stress model induces changes in neurotransmitters and circulating miRNAs in extracellular vesicles.Heliyon. 2023 Feb 10;9(2):e13442. doi: 10.1016/j.heliyon.2023.e13442. eCollection 2023 Feb. Heliyon. 2023. PMID: 36852042 Free PMC article.
-
Effects of low-doses of methamphetamine on d-fenfluramine-induced head-twitch response (HTR) in mice during ageing and c-fos expression in the prefrontal cortex.BMC Neurosci. 2023 Jan 11;24(1):2. doi: 10.1186/s12868-022-00766-0. BMC Neurosci. 2023. PMID: 36631757 Free PMC article.
-
Local activation of α2 adrenergic receptors is required for vagus nerve stimulation induced motor cortical plasticity.Sci Rep. 2021 Nov 4;11(1):21645. doi: 10.1038/s41598-021-00976-2. Sci Rep. 2021. PMID: 34737352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous